Moreover, SGLT-2 inhibitors were associated with a lower risk for HHF as compared with GLP-1RA (RR = 0.76, 95% CI 0.680.85)
The FLOW study particularly indicated that semaglutide decreased the progression to end-stage renal disease by 24% in individuals with diabetic kidney disease (Rossing et al
With manufacturer savings programs, Saxenda can be reduced to approximately $150-200/month for eligible patients
Some employers expressed hope that life-style coaching would allow employees to have an off ramp and stop using GLP-1 drugs after some period of time
I had my nausea meds ready, Id bought small meal containers, I set water reminders on my phone
Noom reports 70% of members experience no side effects versus higher rates with full-dose treatment, potentially improving medication adherence and allowing patients to stick with their treatment plans longer